Senhance Surgical System Cleared for General Surgery

FDA has cleared an Asensus Surgical 510(k) for the Senhance Surgical System and its use in general surgery procedures. “Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform),” the company says. It says the device is designed for complex reconstructive surgeries such as those used to treat reflux and obesity. The clearance says the device is intended to “assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, mobilization, and retraction,” it adds.